Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 3736 AL 3750

AIF, reactive oxygen species, and neurodegeneration: a "complex" problem

Polster BM.

Neurochem Int. 2013 Apr;62(5):695-702. doi: 10.1016/j.neuint.2012.12.002. Epub 2012 Dec 12.

Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration

Chen X, Burdett TC, Desjardins CA, Logan R, Cipriani S, Xu Y, Schwarzschild MA.

Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):300-5. doi: 10.1073/pnas.1217296110. Epub 2012 Dec 17.

Triptolide with potential medicinal value for diseases of the central nervous system

Zheng Y, Zhang WJ, Wang XM.

CNS Neurosci Ther. 2013 Feb;19(2):76-82. doi: 10.1111/cns.12039. Epub 2012 Dec 18.

Topographical differences of brain iron deposition between progressive supranuclear palsy and parkinsonian variant multiple system atrophy

Han YH, Lee JH, Kang BM, Mun CW, Baik SK, Shin YI, Park KH.

J Neurol Sci. 2013 Feb 15;325(1-2):29-35. doi: 10.1016/j.jns.2012.11.009. Epub 2012 Dec 20.

Estrogen regulation of Dkk1 and Wnt/β-Catenin signaling in neurodegenerative disease

Scott EL, Brann DW.

Brain Res. 2013 Jun 13;1514:63-74. doi: 10.1016/j.brainres.2012.12.015. Epub 2012 Dec 19.

In vivo neurochemical imaging of olfactory dysfunction in Parkinson's disease

Bohnen NI, Müller ML.

J Neural Transm (Vienna). 2013 Apr;120(4):571-6. doi: 10.1007/s00702-012-0956-y. Epub 2012 Dec 21.

Effect of subthalamic deep brain stimulation on non-motor fluctuations in Parkinson's disease

Azulay JP, Witjas T, Eusebio A.

J Neural Transm (Vienna). 2013 Apr;120(4):655-7. doi: 10.1007/s00702-012-0958-9. Epub 2012 Dec 23.

L-threo-3,4-dihydroxyphenylserine (L-DOPS) co-administered with entacapone improves freezing of gait in Parkinson's disease

Fukada K, Endo T, Yokoe M, Hamasaki T, Hazama T, Sakoda S.

Med Hypotheses. 2013 Feb;80(2):209-12. doi: 10.1016/j.mehy.2012.11.031. Epub 2012 Dec 21.

mTOR: on target for novel therapeutic strategies in the nervous system

Maiese K, Chong ZZ, Shang YC, Wang S.

Trends Mol Med. 2013 Jan;19(1):51-60. doi: 10.1016/j.molmed.2012.11.001. Epub 2012 Dec 19.

Complex I deficiencies in neurological disorders

Papa S, De Rasmo D.

Trends Mol Med. 2013 Jan;19(1):61-9. doi: 10.1016/j.molmed.2012.11.005. Epub 2012 Dec 19.

"Persistent" hyperkinetic movements after deep brain stimulation of the subthalamic nucleus for Parkinson's disease

Stathis PG, Smpiliris ME, Sakas DE.

Clin Neurol Neurosurg. 2013 Aug;115(8):1493-5. doi: 10.1016/j.clineuro.2012.11.023. Epub 2012 Dec 21.

Bromocriptine loaded chitosan nanoparticles intended for direct nose to brain delivery: pharmacodynamic, pharmacokinetic and scintigraphy study in mice model

Md S, Khan RA, Mustafa G, Chuttani K, Baboota S, Sahni JK, Ali J.

Eur J Pharm Sci. 2013 Feb 14;48(3):393-405. doi: 10.1016/j.ejps.2012.12.007. Epub 2012 Dec 21.

Parkinsonism in multiple sclerosis patients: a casual or causal association?

Pedemonte E, Trabucco E, Cella M, Solaro C.

Parkinsonism Relat Disord. 2013 Apr;19(4):492-3. doi: 10.1016/j.parkreldis.2012.11.021. Epub 2012 Dec 23.

Endogenous morphine and its metabolites in mammals: history, synthesis, localization and perspectives

Laux-Biehlmann A, Mouheiche J, Vérièpe J, Goumon Y.

Neuroscience. 2013 Mar 13;233:95-117. doi: 10.1016/j.neuroscience.2012.12.013. Epub 2012 Dec 21.

Recent advances in herbal medicines treating Parkinson's disease

Li XZ, Zhang SN, Liu SM, Lu F.

Fitoterapia. 2013 Jan;84:273-85. doi: 10.1016/j.fitote.2012.12.009. Epub 2012 Dec 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias